Delving into the Latest Updates on CardioX, Inc. with Synapse

Overview

The study is an open-label, prospective, single-center, non-randomized feasibility study of the Bruxoff(TM) device to identify EMG activity associated with bruxism, and to assess the impact of the TMJ NextGeneration(TM) device upon the occurrence of night-time bruxism events and incidence of migraines and headache in subjects diagnosed with sleep bruxism.

Start Date01 Nov 2014

Sponsor / Collaborator

TMJ Health LLC

[+1]

NCT02516319

/ TerminatedNot Applicable

A Feasibility Study to Determine an Adequate Dose of ICG for the Liver Function Assessment System in Healthy Volunteers

The purpose of this study is to 1) determine the feasibility of using Cardiox Liver Function Assessment System (LFA) to measure indocyanine green (ICG) clearance; 2) determine an adequate dose based on LFA technology and 3) determine an adequate time period for LFA determination.

Start Date01 Sep 2012

Sponsor / Collaborator

CardioX, Inc.

100 Clinical Results associated with CardioX, Inc.

Login to view more data

0 Patents (Medical) associated with CardioX, Inc.

Login to view more data

100 Deals associated with CardioX, Inc.

Login to view more data

100 Translational Medicine associated with CardioX, Inc.

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 31 May 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Other

1

Login to view more data